Skip to main content
OpenTrials

Clinical trial condition

Thrombocytosis

Explore clinical trials studying Thrombocytosis. Study availability and eligibility vary by location and protocol.

177 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytosis trial results

Completed

Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

NCT03745378

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Palacky University and University Hospital Olomouc, Faculty of Medecine Olomouc, Czechia
  • University Hospital RWTH - Department Oncology, Hematology, Hemostaeseology and stem cell transplantation Aachen, Germany
  • Johannes Wesling Academic Medical Center Minden, Germany
  • Meir Medical Center Kfar Saba, Israel
View all 30 locations
View Trial Details
Completed

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

NCT02407080

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Completed

A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera

NCT01901432

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • CHU Amiens - Hôpital Sud Amiens, France
  • Hôpital Morvan - CHRU de Brest Brest, France
  • Hopital Saint Vincent de Paul - GHICL Lille Lille, France
  • Hôpital Saint-Louis (AP-HP), Centre Investigations Cliniques Paris, France
View all 25 locations
View Trial Details
Completed

Research Tissue Bank

NCT00666549

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Palo Alto Medical Foundation Research Institute Palo Alto, California, United States
  • Weill Cornell University Washington D.C., District of Columbia, United States
  • University of Georgetown Washington D.C., District of Columbia, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
View Trial Details
Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

NCT02311569

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View Trial Details

Related conditions